EX-10.2 3 dex102.htm MANUFACTURING TECHNOLOGY TRANSFER & SUPPLY AGREEMENT Confidential MANUFACTURING TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT BY AND BETWEEN ANTIGENICS, INC., A MASSACHUSETTS CORPORATION AND GLAXOSMITHKLINE BIOLOGICALS SA Confidential...Manufacturing Technology Transfer and Supply Agreement • May 5th, 2020 • Delaware
This Manufacturing Technology Transfer and Supply Agreement (this “Agreement”) is made effective this 6th day of July, 2006 (“Effective Date”) by and between Antigenics Inc., a Massachusetts corporation and wholly owned subsidiary of Antigenics Inc., a Delaware corporation, having offices at 3 Forbes Road, Lexington, MA 02421 (“Antigenics MA”), and GlaxoSmithKline Biologicals SA, a Belgian company, having an address at 89 rue de l’Institut, 1330 Rixensart, Belgium (“GSK”) (each singularly a “Party” and collectively the “Parties”).
Binding Letter of Intent July 20, 2007 GlaxoSmithKline Biologicals SA Attention: President and General Manager Dear Sir:Manufacturing Technology Transfer and Supply Agreement • November 14th, 2007 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Massachusetts
Reference is made to that certain Manufacturing Technology Transfer and Supply Agreement by and between Antigenics Inc., a Massachusetts corporation (“Antigenics”) and GlaxoSmithKline Biologicals SA (“GSK”) dated July 6, 2006 (the “Supply Agreement”). This binding letter of intent (“Letter”) will confirm our prior discussions regarding amending the Supply Agreement and entering into a business arrangement to relieve the Parties of their respective purchase and supply obligations under the Supply Agreement (the “Proposed Transaction”). This Letter supersedes any prior letters or discussions regarding the Proposed Transaction. This Letter is intended to create binding legal and contractual obligations of the Parties with respect to matters set forth herein, and upon the breach by a Party of its obligations in any material respect, the injured Party shall have such rights and remedies with respect thereto as are available to it under applicable law. Capitalized terms not defined herein sh
AMENDED AND RESTATED MANUFACTURING TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT BY AND BETWEEN ANTIGENICS, INC., A MASSACHUSETTS CORPORATION AND GLAXOSMITHKLINE BIOLOGICALS SAManufacturing Technology Transfer and Supply Agreement • May 11th, 2009 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
